Skip to content
Toll-Free: 0800 CORDBANK Questions? Request more information here.

Rheumatoid relief in sight for arthritis sufferers

Professor Zhan-guo Li has worked with a team of researchers from Peking University People’s Hospital, China, to carry out a laboratory study in which cord blood stem cells were used to suppress inflammation and weaken the disease.

Professor Li said, “Very little is known about umbilical cord MSCs, and there has been no previous report about their use in the treatment of RA. MSCs can exert profound immunosuppression, which encourages their use in the treatment of autoimmune diseases, such as RA. At present, the most common source of MSCs has been bone marrow. However, aspirating bone marrow is an invasive procedure and the number and the differentiating potential of bone marrow MSCs decrease with age. In contrast, the collection of umbilical cord MSCs does not require any invasive procedure.”

The researchers took immune cells from RA patients and showed that the umbilical MSCs were able to suppress the cells’ proliferation, invasive behavior and inflammatory responses. Systemic infusion of the umbilical MSCs into mice was shown to significantly reduce the severity of collagen-induced arthritis.

Speaking about the results, Professor Li said, “RA imparts a massive burden on health services worldwide and none of the currently used agents reaches long term drug-free remission. Therefore, a new and more effective therapy for RA will be very welcome.”

To read more: http://www.ahealthblog.com/cord-stem-cells-a-potential-arthritis-treatment.html

payment-logos

(Phone) 0800 CORDBANK or +64 9 302 9511 · (Email) [email protected]
PO Box 68757, Wellesley Street, Auckland 1141
© CordBank New Zealand, 2021

 

Still need help to decide if cord blood banking is right for you? Get our:

Call Now Button